ADA2 mutation disrupts the enzyme’s conversion of adenosine and 2′-deoxyadenosine, leading to neutrophil activation, immune dysfunction, vasculopathy, and catalytic dysfunction, resulting in elevated adenosine levels, leading to inflammation, tissue damage, and fibrosis1. Here, ADA2 is linked to vascular disorder.